{"id":"W1698939815","doi":"10.1155/2011/724813","title":"Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Abbott (Canada); University of Calgary","funders":"National Institutes of Health; Otsuka America; GlaxoSmithKline; Biogen; ActoGeniX; Bristol-Myers Squibb; Abbott Laboratories","keywords":"Adalimumab; Medicine; Infliximab; Crohn's disease; Internal medicine; Fistula; Surgery; Adverse effect; Disease; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003631589,0.0003511581,0.0004909815,0.0007135845,0.000130071,0.00003965749,0.0006533167,0.0001335437,0.00002958891],"category_scores_gemma":[0.0003252058,0.0002868368,0.00009183327,0.0002371752,0.0002213351,0.00004484138,0.00006939536,0.0002684317,8.005396e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005148783,"about_ca_system_score_gemma":0.009443296,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6652369,"about_ca_topic_score_gemma":0.9984749,"domain_scores_codex":[0.9970266,0.0003666811,0.0007906636,0.0004625853,0.0002315457,0.001121907],"domain_scores_gemma":[0.9941124,0.0000144562,0.0004236925,0.0005574315,0.0004286671,0.004463314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.299983,0.00008167329,0.6878563,0.00003820855,0.00009917143,0.001917389,0.0004732752,0.00909413,0.000008393436,0.00001374371,0.0003623284,0.00007237362],"study_design_scores_gemma":[0.03293991,0.00118353,0.9649369,0.0002434545,0.00007592644,0.00002886277,0.00004866156,0.00006640863,0.00002409556,0.00001704204,0.0002132893,0.0002218968],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960444,0.00004176353,0.00001238589,0.0007348526,0.0001691821,0.001163118,0.001709724,0.000001525289,0.0001230263],"genre_scores_gemma":[0.9984656,0.000006192233,0.00007611833,0.001222656,0.00005624413,0.00002594993,0.0000624303,0.00004672089,0.00003809949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.333238,"threshold_uncertainty_score":0.9999584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008497716515170643,"score_gpt":0.2081001138199709,"score_spread":0.1996023973048003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}